John Hancock Life Insurance Co. (USA) (Investment Portfolio)

John Hancock Life Insurance Co. (USA) (Investment Portfolio)

John Hancock Life Insurance Co. (USA) (Investment Portfolio)

Overview
Headquarters

128 South Tryon Street,Suite 880,Charlotte, NC 28202-5014

Type of Company

Private

Industries

Investment Services & Portfolio Management
Other Insurance Services

Company Description

John Hancock Life Insurance Co. (USA) is an insurance company headquartered in Boston, Massachusetts. The firm is a subsidiary of John Hancock Financial Services, Inc. and their ultimate parent is Manulife Financial Corp.

Executives & Employees

Interim President & Chief Executive Officer

Senior Managing Director

Vice President & Senior Managing Director

Managing Director

Managing Director

Managing Director

Managing Director

Managing Director

Managing Director

Director

Board of Directors

Former Director at Hancock Capital Management LLC

Former Senior Investment Analyst at John Hancock Life Insurance Company

Paths to John Hancock Life Insurance Co. (USA) (Investment Portfolio)
Potential Connections via
Relationship Science
You
John Hancock Life Insurance Co. (USA) (Investment Portfolio)
Recent Transactions
Details Hidden

Brookfield Infrastructure Partners LP purchases Macquarie District Energy, Inc. from Macquarie Infrastructure Corp., John Hancock Life Insurance Co. (USA) (Investment Portfolio), Macquarie Group Ltd.

Transaction Advisors
Investment Advisor

Advised onBrookfield Infrastructure Partners LP purchases Macquarie District Energy, Inc. from Macquarie Infrastructure Corp., John Hancock Life Insurance Co. (USA) (Investment Portfolio), Macquarie Group Ltd.

Investments
Details Hidden

Macquarie District Energy, Inc. owns and operates heating and cooling facilities. The company is headquartered in New York, NY.

Details Hidden

Berkshire Power Co. LLC owns and operates electric power plants. It provides natural gas and related services. The company was founded on December 15, 1997 and is headquartered in Needham, MA.

Details Hidden

CymaBay Therapeutics, Inc. is a clinical stage company, which engages in the research and development of biopharmaceutical products. Its candidates include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce gout flares and serum uric acid. The company was founded on October 5, 1988 and is headquartered in Newark, CA.